Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 1
1993 1
1997 1
1998 1
1999 1
2000 1
2001 2
2004 1
2005 5
2006 2
2007 3
2008 3
2009 3
2010 3
2011 9
2012 5
2013 6
2014 11
2015 16
2016 24
2017 23
2018 21
2019 16
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

150 results
Results by year
Filters applied: . Clear all The following terms were ignored: %, %, % The following terms were not found in PubMed: 20JH, 5BAuthor
Page 1
Clinic-Based Patellar Mobilization Therapy for Knee Osteoarthritis: A Randomized Clinical Trial.
Sit RWS, Chan KKW, Zou D, Chan DCC, Yip BHK, Zhang DD, Chan YH, Chung VCH, Reeves KD, Wong SYS. Sit RWS, et al. Ann Fam Med. 2018 Nov;16(6):521-529. doi: 10.1370/afm.2320. Ann Fam Med. 2018. PMID: 30420367 Free PMC article. Clinical Trial.
Secondary outcomes included the WOMAC composite, function, and stiffness scores; the visual analog scale score for pain; objective physical function tests (30-s chair stand, 40-m walk test, timed up and go test, and EuroQol-5D). ...
Secondary outcomes included the WOMAC composite, function, and stiffness scores; the visual analog scale score for pain; objective physical …
Early Mobilization Reduces Duration of Mechanical Ventilation and Intensive Care Unit Stay in Patients With Acute Respiratory Failure.
Lai CC, Chou W, Chan KS, Cheng KC, Yuan KS, Chao CM, Chen CM. Lai CC, et al. Arch Phys Med Rehabil. 2017 May;98(5):931-939. doi: 10.1016/j.apmr.2016.11.007. Epub 2016 Dec 13. Arch Phys Med Rehabil. 2017. PMID: 27979608
We did early mobilization twice daily, 5d/wk during family visits (30min each time), and cooperated with family, if possible. ...After protocol group patients had shorter MV durations (4.7d vs 7.5d; P<.001) and ICU stays (6.9d vs 9.9d; P=.001) than did before pro …
We did early mobilization twice daily, 5d/wk during family visits (30min each time), and cooperated with family, if possible. ...Afte …
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Agarwal N, McQuarrie K, Bjartell A, Chowdhury S, Pereira de Santana Gomes AJ, Chung BH, Özgüroğlu M, Juárez Soto Á, Merseburger AS, Uemura H, Ye D, Given R, Cella D, Basch E, Miladinovic B, Dearden L, Deprince K, Naini V, Lopez-Gitlitz A, Chi KN; TITAN investigators. Agarwal N, et al. Lancet Oncol. 2019 Nov;20(11):1518-1530. doi: 10.1016/S1470-2045(19)30620-5. Epub 2019 Sep 29. Lancet Oncol. 2019. PMID: 31578173 Clinical Trial.
Patient-reported outcomes were prespecified exploratory endpoints and were the Brief Pain Inventory-Short Form (BPI-SF), Brief Fatigue Inventory (BFI), Functional Assessment of Cancer Therapy-Prostate (FACT-P), and EuroQoL 5D questionnaire 5 level (EQ-5D-5L). ...FAC …
Patient-reported outcomes were prespecified exploratory endpoints and were the Brief Pain Inventory-Short Form (BPI-SF), Brief Fatigue Inven …
Efficacy and safety of thread embedding acupuncture combined with conventional acupuncture for chronic low back pain: A study protocol for a randomized, controlled, assessor-blinded, multicenter clinical trial.
Leem J, Kim H, Jo HG, Jeon SR, Hong Y, Park Y, Seo B, Cho Y, Kang JW, Kim EJ, Han GY, Kim JS, Lee HJ, Kim TH, Nam D. Leem J, et al. Medicine (Baltimore). 2018 May;97(21):e10790. doi: 10.1097/MD.0000000000010790. Medicine (Baltimore). 2018. PMID: 29794761 Free PMC article. Clinical Trial.
The groups will also be compared with regard to the clinical relevance (minimal clinically important difference), quality of life (3-level version of Euroqol-5D), disability level (Roland and Morris Disability Questionnaire), global assessment (patient global impression of …
The groups will also be compared with regard to the clinical relevance (minimal clinically important difference), quality of life (3-level v …
Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1).
Deodhar AA, Dougados M, Baeten DL, Cheng-Chung Wei J, Geusens P, Readie A, Richards HB, Martin R, Porter B. Deodhar AA, et al. Arthritis Rheumatol. 2016 Dec;68(12):2901-2910. doi: 10.1002/art.39805. Arthritis Rheumatol. 2016. PMID: 27390130 Free PMC article. Clinical Trial.
Patient-reported outcomes included the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BASDAI criteria for 50% improvement (BASDAI 50), Short Form 36 (SF-36) physical component summary (PCS) score and mental component summary (MCS) score, Ankylosing Spondylitis Quali …
Patient-reported outcomes included the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), BASDAI criteria for 50% improvement (BAS …
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.
Chau I, Peck-Radosavljevic M, Borg C, Malfertheiner P, Seitz JF, Park JO, Ryoo BY, Yen CJ, Kudo M, Poon R, Pastorelli D, Blanc JF, Chung HC, Baron AD, Okusaka T, Bowman L, Cui ZL, Girvan AC, Abada PB, Yang L, Zhu AX. Chau I, et al. Eur J Cancer. 2017 Aug;81:17-25. doi: 10.1016/j.ejca.2017.05.001. Epub 2017 Jun 4. Eur J Cancer. 2017. PMID: 28591675 Clinical Trial.
QoL was assessed by FACT Hepatobiliary Symptom Index (FHSI)-8 and EuroQoL (EQ-5D) at baseline; cycles 4, 10, and 16; and end of treatment. ...Compliance with FHSI and EQ-5D was high and similar between groups. In the ITT population, deterioration in FHSI-8, EQ-5D
QoL was assessed by FACT Hepatobiliary Symptom Index (FHSI)-8 and EuroQoL (EQ-5D) at baseline; cycles 4, 10, and 16; and end of treat …
Efficacy of intra-articular hypertonic dextrose prolotherapy versus normal saline for knee osteoarthritis: a protocol for a triple-blinded randomized controlled trial.
Sit RWS, Wu RWK, Reeves KD, Rabago D, Chan DCC, Yip BHK, Chung VCH, Wong SYS. Sit RWS, et al. BMC Complement Altern Med. 2018 May 15;18(1):157. doi: 10.1186/s12906-018-2226-5. BMC Complement Altern Med. 2018. PMID: 29764447 Free PMC article.
The primary outcome will be the Western Ontario McMaster University Osteoarthritis Index pain scale (WOMAC), and secondary outcomes include WOMAC composite score, the WOMAC function and stiffness subscale, the Visual Analogue Score of pain, objective physical function tests (the …
The primary outcome will be the Western Ontario McMaster University Osteoarthritis Index pain scale (WOMAC), and secondary outcomes include …
Psychometric validation of the EuroQoL 5-dimension (EQ-5D) questionnaire in patients with spondyloarthritis.
Tsang HHL, Cheung JPY, Wong CKH, Cheung PWH, Lau CS, Chung HY. Tsang HHL, et al. Arthritis Res Ther. 2019 Jan 30;21(1):41. doi: 10.1186/s13075-019-1826-x. Arthritis Res Ther. 2019. PMID: 30700326 Free PMC article.
Specifically, the relationship between EQ-5D and disease activity and functional scores was studied. RESULTS: EQ-5D scores achieved acceptable internal consistency and reliability. ...A higher disease activity was well-differentiated by EQ-5D, as with the dis …
Specifically, the relationship between EQ-5D and disease activity and functional scores was studied. RESULTS: EQ-5D scores ach …
β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation.
Bae HR, Kim DH, Park MH, Lee B, Kim MJ, Lee EK, Chung KW, Kim SM, Im DS, Chung HY. Bae HR, et al. Oncotarget. 2016 Oct 11;7(41):66444-66454. doi: 10.18632/oncotarget.12119. Oncotarget. 2016. PMID: 27661104 Free PMC article.
Clinical effectiveness of patella mobilisation therapy versus a waiting list control for knee osteoarthritis: a protocol for a pragmatic randomised clinical trial.
Sit RWS, Chan KKW, Yip BHK, Zhang DD, Reeves KD, Chan YH, Chung VCH, Wong SYS. Sit RWS, et al. BMJ Open. 2018 Mar 14;8(3):e019103. doi: 10.1136/bmjopen-2017-019103. BMJ Open. 2018. PMID: 29540410 Free PMC article. Clinical Trial.
The primary outcome is the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale, and secondary outcomes include the WOMAC function and stiffness subscales, scores for objective physical function tests (the 30 s chair stand, 40-metre fast-paced walk …
The primary outcome is the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale, and secondary outcomes incl …
150 results
Jump to page
Feedback